Updated Guidance on COVID-19 Booster Shots

TargetHIV

From the HRSA HIV/AIDS Bureau Update: Special Bulletin - 10/26/21

On Thursday, October 21, the Centers for Disease Control and Prevention (CDC) recommended a booster shot of the Moderna and Janssen (Johnson & Johnson) COVID-19 vaccines in certain populations. See the CDC statement for more information.

These recommendations align with and follow the Food and Drug Administration’s (FDA) authorization of:

  • The use of Moderna's COVID-19 vaccine to be administered as a booster for certain populations.
  • The Janssen (Johnson & Johnson) COVID-19 vaccine for anyone 18 years and older who received that vaccine at least two months ago.
  • The use of all three available COVID-19 vaccines (Moderna, Janssen (Johnson & Johnson), and Pfizer-BioNTech) as “mix and match” boosters for people who have completed their primary vaccination.

The guidelines for COVID-19 boosters vary by vaccine. However, people with HIV who are aged 18 years and older are included as those eligible.


The following resources are available to help Ryan White HIV/AIDS Program health care team members and clinicians understand what this means and assess readiness:

The following upcoming opportunity can also help Ryan White HIV/AIDS Program health care team members and clinicians learn more:

  • Thursday, November 18, 2:00-3:00 PM ET - November HAB You Heard Webinar: Join HRSA’s HIV/AIDS Bureau for our monthly update. This meeting is open to RWHAP recipients, subrecipients, stakeholders, and federal staff and will include updated information about COVID-19 boosters for people with HIV. Register to participate in this session.

We'd like your feedback

Was this page helpful?
I found this page helpful because the content on the page:
Check all that apply
I did not find this page helpful because the content on the page:
Check all that apply
Please include an email address if you would like a response
Please include an email address if you would like a response